Stories about research and scientific development at Mount Sinai
A Novel Approach to Making Organ Transplants Successful
The nearly 35,000 individuals who receive organ transplants each year in the United States face a harsh reality: the immunosuppressive drugs they must take to maintain organ survival also weaken the immune system, breaking down the body’s...
Inaugural Symposium Explores Women’s Health
Why are more women than men hospitalized for schizophrenia after age 50? How should a bipolar pregnant woman be medicated? What should the study of women’s health encompass? These were some of the questions posed recently by leading physician-scientists at...
The Jacobi Medallion: A Celebration of Excellence
Nine accomplished physicians and researchers were honored with the 2019 Jacobi Medallion—one of Mount Sinai’s highest awards—at a special event held at The Plaza on Thursday, March 14. Dennis S. Charney, MD, Anne and Joel Ehrenkranz Dean, Icahn School of Medicine at...
$12.5 Million Grant to Advance Study of Hormone’s Role in Weight Gain and Bone Loss
Researchers at the Icahn School of Medicine at Mount Sinai have been awarded a $12.5 million grant from the National Institute on Aging for a study seeking to advance the treatment of two public health hazards in older adults—osteoporosis and...
Research Is Customizing Artificial Pancreas for Pregnancy
An artificial pancreas system tailored to the specific, and daunting, challenges faced by pregnant women with type 1 diabetes is the goal of a study to be conducted by a consortium of four leading institutions, including the Icahn School of...
Changing the Paradigm for Patients With Treatment-Resistant Depression
The U.S. Food and Drug Administration on March 5 approved SPRAVATO™ (esketamine) CIII nasal spray for the treatment of treatment-resistant depression. Dennis S. Charney, MD, Anne and Joel Ehrenkranz Dean, Icahn School of Medicine at Mount Sinai, is a...
$4 Million Grant for Study of Sickle Cell Treatment
An inhaled treatment that might improve lung function— and reduce the painful symptoms—of patients with sickle cell disease (SCD) is being studied in a clinical trial funded by a $4 million grant from the National Institutes of Health awarded...
Uncovering the Biology of Neurodegeneration
Ivan Marazzi, PhD, Assistant Professor of Microbiology at the Icahn School of Medicine at Mount Sinai, received $2.5 million in funding from the Chan Zuckerberg Initiative (CZI) to further the understanding of the underlying causes of neurodegenerative...
Educating Providers on the Impact of Climate Change
Climate change is taking a toll not just on the environment, but also in the clinic, with a rise in asthma, cardiovascular disease, insect-borne viruses, and heat-related death. That was the urgent message of the inaugural Clinical Climate Change...